Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Xfibra, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

A First-in-human Study of the Safety, Tolerability, and PK of XFB-19 in Healthy Adult Volunteers

Phase 1

Conditions: Idiopathic Pulmonary Fibrosis (IPF)

Interventions: Drug: Placebo
Drug: XFB-19

First Posted Date: 2022-05-05

Last Posted Date: 2022-07-19

Lead Sponsor: Xfibra, Inc.

Target Recruit Count: 40

Registration Number: NCT05361733

Prev
1
Next

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy